References
- Winkelmann A, Perrot S, Schaefer C, Ryan K, Chandran A, Sadosky A, et al. Impact of fibromyalgia severity on health economic costs: results from a European cross-sectional study. Appl Health Econ Health Policy 2011;9:125–36.
- Palstam A, Mannerkorpi K. Work ability in fibromyalgia: an update in the 21st century. Curr Rheumatol Rev 2017;13:180–7.
- Rivera J, Rejas J, Esteve-Vives J, Vallejo MA, Rivera J, Silvela F. Resource utilisation and health care cost in patients diagnosed with fibromyalgia in Spain. Clin Exp Rheumatol 2009;27:39–45.
- Silverman S, Dukes EM, Johnston SS, Brandenburg NA, Sadosky A, Huse DM. The economic burden of fibromyalgia: comparative analysis with rheumatoid arthritis. Curr Med Res Opin 2009;25:829–40.
- Collado A, Gomez E, Coscolla R, Sunyol R, Sole E, Rivera J, et al. Work, family and social environment in patients with fibromyalgia in Spain: an epidemiological study: EPIFFAC study. BMC Health Serv Res 2014;14:513.
- Fitzcharles M-A, Ste-Marie PA, Rampakakis E, Sampalis JS, Shir Y. Disability in fibromyalgia associates with symptom severity and occupation characteristics. J Rheumatol 2016;43:931–6.
- Guymer EK, Littlejohn GO, Brand CK, Kwiatek RA. Fibromyalgia onset has a high impact on work ability in Australians. Intern Med J 2016;46:1069–74.
- Wolfe F, Walitt BT, Katz RS, Häuser W. Social security work disability and itspredictors in patients with fibromyalgia. Arthritis Care Res (Hoboken) 2014;66:1354–63.
- Isomeri R, Mikkelsson M, Partinen M, Kauppi MJ. Severity of symptoms persist for decades in fibromyalgia – a 26 year follow-up study. Clin Rheumatol 2018;37:1383–8.